The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation
within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on Drug Development and Regulation
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of
Drug Development and Regulation.
It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Drug Development and Regulation.
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters.
Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or
theoretical work in all areas of Drug Development and Regulation are cordially invited for presentation at the conference.
The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of
novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers.
Downloadable versions of the check list for
Full-Text Papers and
Abstract Papers.
Please refer to the
Paper Submission Guideline,
Abstract Submission Guideline and
Author Information
before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers.
The peer-reviewed conference proceedings are indexed in the Open Science Index,
Google Scholar,
Semantic Scholar,
Zenedo,
BASE,
WorldCAT,
Sherpa/RoMEO,
and other index databases. Impact Factor Indicators.
Special Journal Issues
19. International Conference on Drug Development and Regulation has teamed up with the Special Journal Issue on
Drug Development and Regulation.
A number of selected high-impact full text papers will also be considered for the special journal issues.
All submitted papers will have the opportunity to be considered for this Special Journal Issue.
The paper selection will be carried out during the peer review process as well as at the conference presentation stage.
Submitted papers must not be under consideration by any other journal or publication.
The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly.
Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor.
To participate as a sponsor or exhibitor, please download and complete the
Conference Sponsorship Request Form.
Selected Papers
-
An Exploration of Chinese Foreign Direct Investment in Africa from Ethical and Cultural Perspectives
Yongsheng Guo, Mirza Muhammad Naseer, Xiaoxian Zhu
-
Dental Ethics versus Malpractice, as Phenomenon with a Growing Trend
Saimir Heta, Kers Kapaj, Rialda Xhizdari, Ilma Robo
-
Malpractice, Even in Conditions of Compliance with the Rules of Dental Ethics
Saimir Heta, Kers Kapa, Rialda Xhizdari, Ilma Robo
-
Ethically Integrating Robots in Elder Care
Suresh Lokiah, Samarth Suresh, Yashaswini Vismaya, Sudha Jamthe
-
Metaverse as a Form of Reality and the Impact of Metaverse in Higher Education
Josefina Bengoechea, Alex Bell
-
Flipped Classroom in Bioethics Education: A Blended and Interactive Online Learning Courseware that Enhances Active Learning and Student Engagement
Molly P. M. Wong
-
An Overview of Technology Availability to Support Remote Decentralized Clinical Trials
S. Huber, B. Schnalzer, B. Alcalde, S. Hanke, L. Mpaltadoros, T. G. Stavropoulos, S. Nikolopoulos, I. Kompatsiaris, L. Pérez-Breva, V. Rodrigo-Casares, J. Fons-Martínez, J. de Bruin
-
Public Service Ethics in Public Administration: An Empirical Investigation
Kalsoom Sumra
-
The Internet of Healthcare Things: A European Perspective and a Review of Ethical Concerns
M. Emmanouilidou
-
Corporate Social Responsibility Disclosure, Tax Aggressiveness and Sustainability Report Assurance: Evidence from Thailand
Eko Budi Santoso, Kazia Laturette, Stanislaus Adnanto Mastan
-
Application of Western and Islamic Philosophy to Business Ethics
Elmamy Ahmedsalem
-
Regulation, Co-Regulation and Self-Regulation of Civil Unmanned Aircrafts in Europe
M. de Miguel Molina, V. Santamarina Campos, M. V. Segarra Oña, B. de Miguel Molina
-
The Emerging Global Judicial Ethics: Issues and Problems
Caroline Foulquier-Expert
-
Patient Support Program in Pharmacovigilance: Foster Patient Confidence and Compliance
Atul Khurana, Rajul Rastogi, Hans-Joachim Gamperl
-
Corporate Governance and Corporate Social Responsibility: Research on the Interconnection of Both Concepts and Its Impact on Non-Profit Organizations
Helene Eller
Digital Program consists of the e-proceedings book which is available online-only
and includes the conference communications (proceedings abstracts and papers).
Registered participants can access the digitally available conference
proceedings ( and certificates ) by visiting their profile pages.
Pharmacology
Clinical pharmacology
Drug development
New chemical entity development
Pre-clinical development
Clinical phase
Clinical trials
Clinical trial design
Drug design
Drug discovery
Drug repositioning
Cost
Technology
Ethics
Valuation
Success rate
Novel initiatives to boost drug development
Lead compound
Process of drug discovery
Regulatory approval
New drug application
Trial design
Active comparator studies
Master protocol
Clinical trial protocol
Design features
Placebo groups
Duration
Pharmacovigilance
Dose–response relationships
Drug concentration and effect
Model of reaction dynamics
Drug safety
Abstracts/Full-Text Paper Submission Deadline |
|
January 15, 2025 |
Notification of Acceptance/Rejection |
|
January 31, 2025 |
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline |
|
March 22, 2025 |
Conference Dates |
|
April 17-18, 2025 |